Analysis of National Sample Cohort From Korea for Epidemiological and Prognostic Aspects of Parkinson's Disease According to Time of Onset

基于韩国全国样本队列的帕金森病流行病学和预后特征分析(按发病时间分层)

阅读:1

Abstract

BACKGROUND: Parkinson's disease (PD) affects adults of all ages, with prognostic aspects varying based on the age of onset. This study compared the prognostic aspects of early-onset PD (EOPD) and late-onset PD (LOPD) in South Korea. METHODS: We analyzed PD patients aged ≥ 20 years registered at the National Sample Cohort between 2002 and 2019. PD patients were categorized into EOPD and LOPD. Five randomly selected individuals without PD were included as controls. Epidemiological data were analyzed for the two groups. Medical and socioeconomic variables, including body mass index (BMI), Charlson Comorbidity Index (CCI), smoking, and household income, were compared to controls to identify prognostic factors. RESULTS: PD incidence and prevalence per 100,000 significantly increased from 11.36 and 29.15 in 2003 to 26.10 and 174.52 in 2018, respectively. The proportion of EOPD among the PD patients decreased from 8.81% to 4.42%. LOPD patients had higher CCI scores than EOPD patients, and there were no significant changes in either group after 3 years from the index date. BMI significantly decreased in both LOPD and its control group 3 years after the index date. After the index date, smoking rate significantly decreased in LOPD and controls groups, but not in EOPD. EOPD patients exhibited significant differences in household income after 3 years from the index date. CONCLUSION: PD incidence and prevalence gradually increased from 2003 to 2018, while the proportion of EOPD patients gradually decreased from a high value of 8.81%. For 3 years after PD diagnosis, EOPD and LOPD patients exhibited different comorbidities, smoking rate, and BMI patterns. EOPD patients were more vulnerable to negative economic outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。